Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,655 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A betting meme links celebrity attendance to home-team losses, prompting bettors to rethink risk in personal finance ...
Forgotten DeFi contracts lingering on-chain pose a fresh risk. The next defi drain could hinge on legacy pools and re...
Domestic fares are climbing at a pace well above international routes this summer, signaling a shift in airline prici...
Costco has publicly reaffirmed that the iconic $1.50 hot dog and soda combo will stay at its current price, signaling...
The nobel laureate joseph stiglitz warns that AI’s hunger for internet chatter could degrade the data powering market...
A Fortune interview reveals that Trump’s leadership model succession may not be transferrable, prompting investors an...
KeyBanc boosts Okta's target to $103 from $95, citing a brighter security spending outlook and the central role of id...
Bitcoin is trading in a lower gear as institutional demand wanes and macro pressures mount. ETF outflows and tepid on...
A U.S. equity ETF with about $11 billion in assets is beating the broad market by favoring profitable, attractively v...
Bitwise CIO Matt Hougan rejects blame for Bitcoin's decline, framing it as a crypto winter phenomenon driven by risk ...
Hyperliquid’s HIP-3 markets surged to $1.43 billion in open interest, driven by around-the-clock tokenized asset trad...